Printed from https://fyi.org.nz/similar/request/26432-amendment-to-product-detail-for-comirnaty?page=2 on July 28, 2026 16:58

Requests similar to 'Amendment to Product Detail for Comirnaty' (page 2)

Covid 19 vaccine order documentation
Response by Ministry of Business, Innovation & Employment to Catherine Jamieson on .
Long overdue.
Kia ora Catherine   Please see attached our response to your request for information under the Official Information Act 1982. Ngā mihi nui, Min...
Risks Outweigh Benefits to Children
Request to Ministry of Health by Chris McCashin. Annotated by Mr Rodgers on .
Long overdue.
"Do people know that the pfizer/biontech and comirnaty are actually two vaccines" Did you actually read the link you provided? Quote: "COMIRNATY (C...
Advance Purchase Agreements for Covid-19 Vaccines
Response by Ministry of Business, Innovation & Employment to Catherine Jamieson on .
Partially successful.
Dear Catherine,   Please find attached a letter advising that your request has been transferred to the Ministry of Health.   Best regards,  ...
Comirnaty (JN.1) vaccine
Request sent to Pharmaceutical Management Agency by Catherine Jamieson on .
Successful.
Is the Comirnaty (JN.1) vaccine being purchased under an Advance Purchase Agreement (APA) as earlier versions were? If it is not please advise wha...
Further review of COVID-19 vaccination in NZDF baseline schedule triggered by 11 March 2026 Immunisation Handbook change (ref 33924 / OIA-2026-5687)
Response by New Zealand Defence Force to Mr Richards on .
Awaiting classification.
Good afternoon Mr Richards Please find attached the response to your request for information. Regards Corporate and Ministerial Services Office of...
Medsafe’s Clinical Evaluation report for Comirnaty (COVID-19 mRNA Vaccine) and communications with responsible authorities
Request sent to Ministry of Health by John on .
Long overdue.
To whom it may concern at the Ministry of Health, I am requesting details of communications from Medsafe and/or the Ministry of Health to responsible...
Medsafe’s Clinical Evaluation report for Comirnaty (COVID-19 mRNA Vaccine) and communications with responsible authorities
Request sent to Ministry of Health by John on .
Awaiting classification.
To whom it may concern at the Ministry of Health, This is a repeat of my request for information under Official Information Act 1982 which I made on...
request to Director of the National Immunisation Programme, Astrid Koornneef
Response by Ministry of Health to Tracy Livingston on .
Partially successful.
Kia ora Tracy, Please see attached a letter regarding your request for official information. Ngā mihi     OIA Services Team Manatū Hauora | M...
MOH attempts to overcome vaccine hesitancy on grounds of objection to abortion
Response by Ministry of Health to Jeremy Nimmo on .
Refused.
Tēnā koe Jeremy,   Thank you for your email to the Ministry of Health (the Ministry) on 23 December 2021 for:   “… all communications, advice,...
Comirnaty (COVID-19 mRNA vaccine) with active ingredient BNT162b2
Request sent to Ministry of Health by Heather Darby on .
Refused.
Please provide any and all information that has been provided to the Ministry of Health or Medsafe pertaining to the product Comirnaty (COVID-19 mRN...
studies used showing Comirnaty BioNTech safe
Response by New Zealand Blood and Organ Service to Tracy Livingston on .
Information not held.
Kia ora Tracy   In response to your Official Information Act (OIA) request received on 1 December as below:   Please send me all the studies a...
Supporting evidence to debunked misconceptions as published by the Nz Herald in support of the MoH
Request sent to Ministry of Health by Nastassja Catmull-Gillespie on .
Awaiting classification.
Dear Ministry of Health I’d like to request evidence surrounding several of the claims made in an NZ herald article dated 24/09/2021 titled; 10 of th...
Adverse Events following Covid Injection by Pfizer batch
Request sent to Ministry of Health by Catherine Jamieson on .
Refused.
As provided in H2023033887 for batches FK0892, FK9797, FF2387, FE8163, FK0115, FH4752 and FK9414 please provide the number of adverse events reporte...
Cholesterol ingredient of Comirnaty and its half life
Request sent to Ministry of Health by Erika Whittome on .
Long overdue.
I note the Comirnaty product lists cholesterol as an ingredient in the "6.1 List of excipients" https://www.medsafe.govt.nz/profs/Datasheet/c/Comirn...
Summary of all death's or all age's and all causes from the vaccine monitored group
Request to Ministry of Health by Kiwi. Annotated by victor on .
Awaiting classification.
baseline underreporting rate being used in the background rates comparison. There can't be a meaningful background rates comparison. Baseline und...
Importation of Medicines by the Crown
Response by Ministry of Health to Catherine Jamieson on .
Partially successful.
Kia ora,   Please find attached the response to your request for official information.   Ngā mihi     OIA Services Team Ministry of Heal...
Receipt of Clinical Study C4591007
Response by Ministry of Health to Catherine Jamieson on .
Information not held.
Kia ora Catherine     Please find attached a letter regarding your requests for information. We look forward to your response.   Ngā mihi...
Doses of Covid 19 Vaccine Pfizer Batch FG3716 Administered
Response by Health New Zealand to Catherine Jamieson on .
Successful.
Kia ora Catherine,    Thank you for your request for information. Please find attached our response to your request.   If you have any questions,...
Astra Zeneca
Response by Chris Hipkins to M.R.M. on .
Partially successful.
Kia ora M.R.M Please find attached a letter regarding your request for information. Ngā mihi OIA Services Government Services Office of the Dir...
Graphene Oxide
Response by Ministry of Health to Chris McCashin on .
Partially successful.
Kia ora Chris     Thank you for your follow up email.   The data sheet lists the ingredients which includes the inactive excipients. Data sh...
Funding sources for James Usher & specific studies to back up his claim that mRNA does not stay in vaccinated blood?
Response by University of Otago to Nigel Gray on .
Successful.
Kia ora Nigel Please see attached the University of Otago's response to your Official Information Act request dated 8 December 2022. Ngā mihi Kelsey...
Follow up questions to H2023031262
Request sent to Ministry of Health by Catherine Jamieson on .
Partially successful.
This is a request for information pursuant to the Official Information Act and are questions arising from OIA response H2023031262. 1. How many re...
Suspect Medicine Vaccine Death
Request to Ministry of Health by Chris McCashin. Annotated by victor on .
Partially successful.
Additionally. Without transparency of the baseline underreporting rate being used in the background rates comparison. There can't be a meaningful b...
Kostaive self-amplifying mRNA in New Zealand
Request to Pharmaceutical Management Agency by John Armstrong. Annotated by SPENCER JONES on .
Successful.
Public Annotation – Context and Related FYI Threads (Kostaive / sa-mRNA) This request sought clarification of PHARMAC’s earlier answer regarding Kost...
Risk/Benefit to Pregnant Women
Response by Ministry of Health to J Bruning on .
Successful.
Kia ora J Bruning     Please find attached a letter regarding your request for information. Under section 28(3) of the Act you have the right to as...